Rheumatology NewsBig pharma says it can’t drop drug list prices aloneFebruary 27, 2019Business of Medicine
Rheumatology NewsTalk about déjà vu: Senators set to re-enact drug price hearing of 60 years agoFebruary 25, 2019Business of Medicine
Rheumatology NewsLawsuit against ABIM draws $200,000 in donation supportFebruary 21, 2019Business of Medicine
Rheumatology NewsONC aims to help docs, patients with information sharing in proposed ruleFebruary 13, 2019Business of Medicine
Rheumatology NewsSurvey: Health care costs, access unlikely to improve in 2019February 13, 2019Business of Medicine
Rheumatology NewsTrump administration salutes parade of generic drug approvals, but hundreds aren’t for saleFebruary 8, 2019Business of Medicine
Rheumatology NewsPresident Trump calls for end to HIV/AIDS, pediatric cancerFebruary 6, 2019PediatricsBusiness of Medicine
Rheumatology NewsWinners and losers under bold Trump plan to slash drug rebate dealsFebruary 4, 2019Business of Medicine
Rheumatology NewsCMS proposing more flexibility in Medicare Advantage, Part DFebruary 3, 2019Business of Medicine
Rheumatology NewsDrug-pricing policies find new momentum as ‘a 2020 thing’January 25, 2019Business of Medicine
Rheumatology NewsTrump zeroes in on surprise medical bills in White House chat with patients, expertsJanuary 24, 2019Business of Medicine
Rheumatology NewsGoFundMe CEO: ‘Gigantic gaps’ in health system showing up in crowdfundingJanuary 17, 2019Business of Medicine
